X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12744) 12744
Book Review (2766) 2766
Publication (889) 889
Book Chapter (72) 72
Dissertation (16) 16
Conference Proceeding (14) 14
Book / eBook (10) 10
Magazine Article (5) 5
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
efficacy (10559) 10559
index medicus (10533) 10533
humans (9478) 9478
female (6026) 6026
male (5679) 5679
middle aged (4537) 4537
treatment outcome (3784) 3784
adult (3738) 3738
safety (3498) 3498
aged (3370) 3370
double-blind (2252) 2252
pharmacology & pharmacy (1998) 1998
double-blind method (1819) 1819
care and treatment (1816) 1816
clinical trials (1800) 1800
abridged index medicus (1723) 1723
drug therapy (1697) 1697
therapy (1562) 1562
analysis (1466) 1466
adolescent (1315) 1315
oncology (1278) 1278
animals (1202) 1202
cardiac & cardiovascular systems (1195) 1195
research (1140) 1140
prospective studies (1104) 1104
health aspects (1027) 1027
time factors (1007) 1007
aged, 80 and over (1000) 1000
management (998) 998
young adult (946) 946
drug therapy, combination (937) 937
trial (932) 932
immunology (925) 925
follow-up studies (922) 922
medicine, general & internal (920) 920
patients (890) 890
dose-response relationship, drug (826) 826
surgery (811) 811
risk factors (806) 806
medicine & public health (787) 787
cancer (783) 783
medical research (780) 780
studies (777) 777
randomized controlled trials as topic (758) 758
clinical neurology (731) 731
mortality (713) 713
prevention (709) 709
retrospective studies (696) 696
quality of life (685) 685
drug administration schedule (681) 681
dosage and administration (669) 669
children (664) 664
child (651) 651
gastroenterology & hepatology (649) 649
metaanalysis (637) 637
psychiatry (624) 624
internal medicine (600) 600
severity of illness index (594) 594
usage (593) 593
chemotherapy (584) 584
disease (559) 559
medicine, experimental (553) 553
medicine, research & experimental (553) 553
urology & nephrology (551) 551
placebo-controlled trial (549) 549
pharmacokinetics (541) 541
pain (532) 532
multicenter (530) 530
tolerability (528) 528
quality-of-life (525) 525
risk (505) 505
placebo (497) 497
survival (480) 480
patient outcomes (464) 464
clinical trials as topic (443) 443
infectious diseases (433) 433
neurosciences (433) 433
administration, oral (430) 430
medicine (424) 424
clinical-trials (422) 422
vaccines (419) 419
drug dosages (415) 415
prognosis (414) 414
article (411) 411
combination (407) 407
randomized controlled-trial (407) 407
comparative analysis (400) 400
meta-analysis (399) 399
diabetes (394) 394
respiratory system (390) 390
outcomes (379) 379
diagnosis (377) 377
recurrence (376) 376
cardiovascular (364) 364
dermatology (362) 362
hypertension (361) 361
endocrinology & metabolism (357) 357
allergy (355) 355
mice (355) 355
rheumatology (354) 354
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
OISE - Stacks (3) 3
UofT at Mississauga - Stacks (3) 3
Robarts - Stacks (2) 2
UofT at Scarborough - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Providence Healthcare - Stacks (1) 1
West Park Healthcare Centre - Hospital Department (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12782) 12782
French (18) 18
German (12) 12
Russian (8) 8
Spanish (8) 8
Korean (4) 4
Polish (3) 3
Italian (2) 2
Japanese (2) 2
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Chest, ISSN 0012-3692, 01/2005, Volume 127, Issue 1, pp. 171 - 177
Idiopathic pulmonary fibrosis (IPF) is a devastating disease, yet validated, reliable criteria for evaluating patient response to therapies in clinical trials... 
mortality | efficacy end points | idiopathic pulmonary fibrosis | percentage of predicted FVC | arterial-alveolar pressure gradient | Percentage of predicted FVC | Arterial-alveolar pressure gradient | Efficacy end points | Idiopathic pulmonary fibrosis | Mortality
Journal Article
Journal Article
CHEST, ISSN 0012-3692, 01/2005, Volume 127, Issue 1, pp. 171 - 177
Background: Idiopathic pulmonary fibrosis (IPF) is a devastating disease, yet validated, reliable criteria for evaluating patient response to therapies in... 
SURVIVAL | efficacy end points | RESPIRATORY SYSTEM | mortality | INTERSTITIAL PNEUMONIA | idiopathic pulmonary fibrosis | percentage of predicted FVC | arterial-alveolar pressure gradient | GAMMA-1B
Journal Article
Journal Article
Canadian Journal of Cardiology, ISSN 0828-282X, 2016, Volume 32, Issue 11, pp. 1356.e21 - 1356.e28
Abstract Composite end points are frequently used in clinical trials of investigational treatments for acute heart failure, eg, to boost statistical power and... 
Cardiovascular | ISSUES | DESIGN | CARDIAC & CARDIOVASCULAR SYSTEMS | THERAPY | EFFICACY | RATIONALE | CLINICAL-TRIALS | DEVICES | Heart Failure - therapy | Treatment Outcome | Research Design | Humans | Endpoint Determination | Randomized Controlled Trials as Topic | Index Medicus
Journal Article
The American Journal of Gastroenterology, ISSN 0002-9270, 04/2010, Volume 105, Issue 4, pp. 731 - 735
Journal Article
Expert Review of Clinical Pharmacology, ISSN 1751-2433, 01/2016, Volume 9, Issue 1, pp. 81 - 89
Older patients with various degrees of frailty and disability, a key population target of pharmacological interventions in acute and chronic disease states,... 
frailty | functional status | pharmacodynamics | safety | therapeutic goals | drug development | older adults | pharmacokinetics | efficacy | MULTIDIMENSIONAL PROGNOSTIC INDEX | ADULTS | COGNITIVE IMPAIRMENT | COMPREHENSIVE GERIATRIC ASSESSMENT | BLOOD-PRESSURE | ALL-CAUSE MORTALITY | PHARMACOLOGY & PHARMACY | PEOPLE | TERM MORTALITY | POLYPHARMACY
Journal Article
Expert Review of Gastroenterology and Hepatology, ISSN 1747-4124, 06/2011, Volume 5, Issue 3, pp. 293 - 295
Journal Article